Invesco’s Medline Inc MDLN Stock Holding History

Invesco’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$933M	Buy	20,963,615 +18,434,106	+729%	+$814M	0.09%	186
2025 Q4	$106M	Buy	+2,529,509	New	+$107M	0.01%	819

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco's MDLN Position: Q1 2026 in Review

Invesco increased its Medline Inc (MDLN) stake by 729% in Q1 2026, buying an estimated $814M and bringing the position to 20,963,615 shares worth $933M. The position accounts for 0.09% of the portfolio, ranked #186.

Invesco first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Invesco held 20,963,615 shares of Medline Inc worth $933M as of Q1 2026.
Invesco bought 18,434,106 Medline Inc shares in Q1 2026, an estimated $814M.
Medline Inc made up 0.09% of Invesco's portfolio in Q1 2026, its #186 holding.
Invesco first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.